SFE Investment Counsel’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-44,000
Closed -$180K 124
2022
Q1
$180K Hold
44,000
0.05% 122
2021
Q4
$157K Hold
44,000
0.04% 119
2021
Q3
$160K Sell
44,000
-4,000
-8% -$14.5K 0.04% 118
2021
Q2
$209K Sell
48,000
-10,000
-17% -$43.5K 0.06% 115
2021
Q1
$238K Sell
58,000
-2,000
-3% -$8.21K 0.07% 112
2020
Q4
$239K Hold
60,000
0.08% 107
2020
Q3
$162K Hold
60,000
0.06% 108
2020
Q2
$165K Hold
60,000
0.07% 102
2020
Q1
$142K Hold
60,000
0.08% 101
2019
Q4
$282K Hold
60,000
0.12% 99
2019
Q3
$201K Hold
60,000
0.09% 115
2019
Q2
$197K Hold
60,000
0.08% 109
2019
Q1
$182K Hold
60,000
0.08% 112
2018
Q4
$163K Hold
60,000
0.08% 116
2018
Q3
$202K Hold
60,000
0.08% 125
2018
Q2
$155K Hold
60,000
0.06% 124
2018
Q1
$132K Hold
60,000
0.07% 105
2017
Q4
$119K Hold
60,000
0.05% 113
2017
Q3
$194K Hold
60,000
0.08% 113
2017
Q2
$193K Hold
60,000
0.08% 107
2017
Q1
$170K Hold
60,000
0.06% 109
2016
Q4
$123K Hold
60,000
0.05% 103
2016
Q3
$63K Hold
60,000
0.03% 91
2016
Q2
$63K Hold
60,000
0.03% 92
2016
Q1
$52K Hold
60,000
0.02% 95
2015
Q4
$73K Hold
60,000
0.03% 92
2015
Q3
$102K Hold
60,000
0.05% 92
2015
Q2
$125K Buy
60,000
+35,000
+140% +$72.9K 0.05% 99
2015
Q1
$68K Hold
25,000
0.03% 90
2014
Q4
$64K Hold
25,000
0.03% 89
2014
Q3
$46K Hold
25,000
0.02% 87
2014
Q2
$67K Hold
25,000
0.03% 86
2014
Q1
$87K Hold
25,000
0.04% 85
2013
Q4
$112K Hold
25,000
0.05% 87
2013
Q3
$101K Sell
25,000
-5,000
-17% -$20.2K 0.05% 81
2013
Q2
$125K Buy
+30,000
New +$125K 0.06% 78